ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Side-Chain Asymmetry in Quinoxaline Copolymer Donors Enables Optimal Morphology and Improved Charge Dynamics for High-Efficiency Organic Solar Cells.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
All-polymer solar cells (all-PSCs) have attracted increasing attention owing to their superior mechanical robustness, morphological stability, and solution-processability. However, intricate intermolecular interactions hinder the precise regulation of donor-acceptor miscibility and phase separation, thereby restricting the formation of ideal donor-acceptor interpenetrating networks and favorable charge dynamics. Herein, an asymmetric side-chain strategy is developed for a quinoxaline-based polymer donor (PBAQ6) to precisely modulate donor and acceptor miscibility. Systematic studies demonstrate that the side-chain structure could effectively modulate the film morphology features and charge dynamics of the active layer. Notably, the PBAQ6 polymer with an asymmetric side-chain configuration achieves reasonable donor-acceptor miscibility with the PYF-T-o polymer acceptor. Consequently, the PBAQ6:PYF-T-o-based binary all-PSCs deliver a power conversion efficiency (PCE) of 18.35%, and a further enhanced PCE of 19.52% is achieved for the ternary all-PSCs with a small amount of PBQ12 as a second polymer donor, which ranks among the best values reported so far. Overall, this work demonstrates that, within the investigated quinoxaline-based polymer-donor platform, asymmetric side-chain engineering can concurrently regulate donor-acceptor miscibility, active-layer morphology, and bulk charge dynamics, thereby providing a useful molecular-design principle for the development of high-performance all-polymer solar cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.